1734-1735 / 2437
•
Phase 0
Biological proof of concept /
biodistribution
•
Phase I
Determination of safety, tolerability
and maximum tolerated dose
•
Phase II
Suggestion of efficacy
•
Phase III
Proof of efficacy
•
Phase IV
Optimization of therapy and new
patient populations (children, elderly patients)
Classification of clinical trials